Knowledge, Perceptions, and Self-Reported Rates of Influenza Immunization among Canadians at High Risk from Influenza: A Cross-Sectional Survey

Author:

Roumeliotis Paul1,Houle Sherilyn K. D.2ORCID,Johal Ajit3ORCID,Roy Bertrand4,Boivin Wendy4

Affiliation:

1. School of Epidemiology and Public Health, University of Ottawa, Ottawa, ON K1N 6N5, Canada

2. School of Pharmacy, University of Waterloo, Waterloo, ON N2L 3G1, Canada

3. Travelrx and Immunize.io, Vancouver, BC V5Z 3Y1, Canada

4. CSL Seqirus Inc., Kirkland, QC H9H 4M7, Canada

Abstract

The Public Health Agency of Canada recommends that 80% of high-risk persons, including adults aged ≥65 years and 18–64 years with certain comorbidities, be vaccinated against influenza. During the 2022–2023 influenza season, we conducted an online survey of 3000 Canadian residents aged ≥18 years randomly recruited from the Léger Opinion (LEO) consumer panel to assess knowledge and perceptions about influenza vaccination as well as survey self-reported vaccination rates. Overall, 47.3% received an influenza vaccination during the 2022–2023 season. Vaccination rates among persons aged 18–64 years with high-risk medical conditions (n = 686) and among adults aged ≥65 years (n = 708) were 46.4% and 77.4%, respectively; 77.8% and 88.5%, respectively, believed influenza vaccination was important for people at high risk from influenza. Only 35.8% of adults aged 18–64 years with comorbidities were aware of being at high risk; 66.0% of this group was vaccinated against influenza, compared with 37.0% of those unaware of being at high-risk. During 2022–2023, 51.3% of people aged ≥65 years and 43.0% of people aged 18–64 years with comorbidities discussed influenza vaccination with healthcare providers. These findings suggest gaps in education regarding the importance of influenza vaccination among people at risk of influenza complications.

Funder

CSL Seqirus Inc.

Publisher

MDPI AG

Subject

Pharmacology (medical),Infectious Diseases,Drug Discovery,Pharmacology,Immunology

Reference18 articles.

1. Role of acute infection in triggering acute coronary syndromes;Madjid;Lancet Infect. Dis.,2010

2. Association of Influenza Vaccination with Cardiovascular Risk: A Meta-analysis;Behrouzi;JAMA Netw. Open,2022

3. Intricate interplay between COVID-19 and cardiovascular diseases;Keri;Rev. Med. Virol.,2021

4. Public Health Agency of Canada (2023, March 16). Canadian Immunization Guide Chapter on Influenza and Statement on Seasonal Influenza Vaccine for 2022–2023. Available online: https://www.canada.ca/en/public-health/services/publications/vaccines-immunization/canadian-immunization-guide-statement-seasonal-influenza-vaccine-2022-2023.html.

5. National Influenza Annual Report, Canada, 2021–2022: A brief, late influenza epidemic;Buckrell;Can. Commun. Dis. Rep. Relev. Des. Mal. Transm. Can.,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3